Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.68 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | HPGD | P15428 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | MMP3 | P08254 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL446362 | 0.93 | HSP90AA1 (0.63) | HSP90AA1HSP90AB1ALDH1A1MAPTHPGD | |
| SCHEMBL445761 | 0.93 | HSP90AA1 (0.59) | HSP90AA1HSP90AB1ALDH1A1MAPTHPGD | |
| SCHEMBL445596 | 0.93 | HSP90AA1 (0.59) | HSP90AA1HSP90AB1ALDH1A1MAPTHPGD | |
| SCHEMBL447212 | 0.90 | HSP90AA1 (0.56) | HSP90AA1HSP90AB1ALDH1A1MAPTHPGD | |
| SCHEMBL446749 | 0.90 | HSP90AA1 (0.59) | HSP90AA1HSP90AB1ALDH1A1MAPTHPGD | |
| SCHEMBL446377 | 0.89 | HSP90AA1 (0.55) | HSP90AA1HSP90AB1ALDH1A1MAPTLMNA | |
| SCHEMBL447714 | 0.89 | HSP90AA1 (0.55) | HSP90AA1HSP90AB1ALDH1A1MAPTHPGD | |
| SCHEMBL450425 | 0.89 | HSP90AA1 (0.55) | HSP90AA1HSP90AB1ALDH1A1MAPTLMNA | |
| SCHEMBL449018 | 0.89 | HSP90AA1 (0.55) | HSP90AA1HSP90AB1ALDH1A1MAPTHPGD | |
| SCHEMBL448996 | 0.89 | HSP90AA1 (0.55) | HSP90AA1HSP90AB1ALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9156783-B2 | Compounds for treating proliferative disorders | SYNTA PHARMACEUTICALS CORP. (US) | 2015-10-13 | — | — | US | disclosed |
| US-9156783-B2 | Compounds for treating proliferative disorders | SYNTA PHARMACEUTICALS CORP. (US) | 2015-10-13 | — | — | US | disclosed |
| US-20150025042-A1 | Compounds For Treating Proliferative Disorders | SYNTA PHARMACEUTICALS CORP. (US) | 2015-01-22 | — | — | US | disclosed |
| US-20150025042-A1 | Compounds For Treating Proliferative Disorders | SYNTA PHARMACEUTICALS CORP. (US) | 2015-01-22 | — | — | US | disclosed |
| US-8680100-B2 | Sulfonylhydrazide compounds for treating proliferative disorders | SYNTA PHARMACEUTICALS CORP. (US) | 2014-03-25 | — | — | US | disclosed |
| US-8609720-B2 | Compounds for treating proliferative disorders | SYNTA PHARMACEUTICALS CORP. (US) | 2013-12-17 | — | — | US | disclosed |
| US-20120065206-A1 | COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS | SYNTA PHARMACEUTICALS CORP. (US) | 2012-03-15 | — | — | US | disclosed |
| US-20100081635-A1 | COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS | SYNTA PHARMACEUTICALS CORP. | 2010-04-01 | — | — | US | disclosed |
| US-20100081635-A1 | COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS | SYNTA PHARMACEUTICALS CORP. | 2010-04-01 | — | — | US | disclosed |
| US-20100081635-A1 | COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS | SYNTA PHARMACEUTICALS CORP. | 2010-04-01 | — | — | US | disclosed |
| EP-2057117-A2 | COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS | Synta Pharmaceuticals Corporation (US) | 2009-05-13 | — | — | EP | disclosed |
| WO-2008024303-A2 | COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS | SYNTA PHARMACEUTICALS CORP. (US) | 2008-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081635-A1 | COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS | HSPB1, HSP90AB1, HSPA1B | HSP90AA1 10/4885HSP90AB1 2/4885ALDH1A1 782/4885 |
| US-20150025042-A1 | Compounds For Treating Proliferative Disorders | HSP90AB1, HSPB1, HSP90AB2P | HSP90AA1 9/4885HSP90AB1 1/4885ALDH1A1 893/4885 |
| US-20120065206-A1 | COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS | PKD1, PKD2, PCNA | HSP90AA1 2300/4885HSP90AB1 1711/4885ALDH1A1 1351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.